Načítá se...
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
BACKGROUND: Medulloblastoma is the most common malignant brain tumor in children. Current standard treatments cure 40%–60% of patients, while the majority of survivors suffer long-term neurological sequelae. The identification of 4 molecular groups of medulloblastoma improved the clinical management...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483072/ https://ncbi.nlm.nih.gov/pubmed/25253417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou234 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|